The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This report aims to provide a ...

Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories.

The country is considered the epicenter of the disease in the Americas, with epidemics reported over the years.

Monkeypox, caused by the monkeypox virus—a close cousin of smallpox—has spread rapidly worldwide. From 2022 to 2025, more ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

The Hawai‘i Department of Health (DOH) has confirmed seven travel-related cases of dengue virus so far in 2025.

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

French President Emmanuel Macron has promised more support to fight chikungunya on La Réunion, after a baby died from the ...

Dengue’s rise in 2024, influenced by climate change and shifting serotypes, underscores the need for effective vaccines to ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations 22.04.2025 / 15:07 CET/CEST The issuer is solely ...